Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NBTX-001 in Panic Disorder
NCT04432155Phase 3Unknown
- Sponsor
- Nobilis Therapeutics
- Start
- Jun 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of xenon in panic disorder, sponsored by Nobilis Therapeutics. Status: unknown.
02
Drugs
xenon
03
Conditions
panic disorder
Beyond the preview
Go deeper on NCT04432155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04432155.